Initial Consultation Your journey begins with a detailed consultation where we evaluate your: Medical history Weight loss goals Body mass index (BMI) Metabolic health This helps determine whether medications like semaglutide or tirzepatide are appropriate for you
The answer is highly personal, depending on various factors unique to your health, lifestyle, and goals
Yes, you can switch from Mounjaro to Wegovy (Ozempic)
Oxidative stress in the pathogenesis of crohns disease and the interconnection with immunological response, microbiota, external environmental factors, and epigenetics

"It's exciting to see these new results from the cardiometabolic post hoc analysis, which showed that while benefits were most pronounced in people who achieved greater than 15% weight loss, clear improvements in glycemic parameters and CV risk factors were observed in patients taking oral semaglutide 25 mg, regardless of how much weight was lost, based on the groups observed." Additional OASIS 4 data Indirect comparison between formulations Data presented from an indirect treatment comparison of the OASIS 4 (oral semaglutide) and STEP 1 (injectable semaglutide) phase 3 clinical trials in adults with obesity and overweight demonstrated that key outcomes like the share of people reaching 5%, 10%, 15%, 20% body weight reductions, positive changes in cardiometabolic markers, and quality of life scores were comparable for the oral and injectable formulations in these trials, respectively
Andrews State Park (#8) in the Panhandle and Honeymoon Island State Park (#10) near Tampa Bay